Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye. The researchers envision the injection being done as an office procedure that could be part of regular patient visits.

The possible treatment, which could become the first non-drug, non-surgical, long-acting therapy for glaucoma, uses the injection of a natural and biodegradable material to create a viscous hydrogel — a wa...

Researchers at Oregon State University are making key advances with a new type of optical sensor that more closely mimics the human eye’s ability to perceive changes in its visual field.

The sensor is a major breakthrough for fields such as image recognition, robotics and artificial intelligence...

Scientists use an extended, 22-year solar cycle to make the forecast. In direct contradiction to the official forecast, a team of scientists led by the National Center for Atmospheric Research (NCAR) is predicting that the Sunspot Cycle that started this fall could be one of the strongest since record-keeping began.

In a new article published in Solar Physics, the research team predicts that Sunspot Cycle 25 will peak with a maximu...

Knocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology enhanced the engineered T cells’ ability to eliminate blood cancers, according to new preclinical data from researchers in the Perelman School of Medicine at the University of Pennsylvania and Penn’s Abramson Cancer Center.

The findings will be presented as an oral presentation at the 62nd American Society of Hematology Annual Meeting & Exposition on Dec. 7 (abstract 554).

The team knocked out the CD5 gene — which encodes for the CD5 protein on the surface of T cells and can inhibit their activation — on CAR T cells using CRISPR-Cas9 and infused them back into mice with T- and B-cell leukemia or lymphoma...